A comparison of placebo response with major depressive disorder in patients recruited through newspaper advertising versus consultation referrals

Psychopharmacology Bulletin

Volumn 33, Issue 4, 1997, Pages 647-651

  Miller, Carol A ^a   Hooper, Cynthia L ^a   Bakish, David ^a,b  

^a ROYAL OTTAWA HOSPITAL   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Clinical trial; Depressive disorder; Double blind; Patient selection; Placebo effect

Indexed keywords

PLACEBO;

ADULT; ADVERTIZING; CLINICAL ARTICLE; CONFERENCE PAPER; CONSULTATION; CONTROLLED STUDY; DEPRESSION; FEMALE; HAMILTON SCALE; HUMAN; MALE; PATIENT COMPLIANCE; PATIENT REFERRAL; PATIENT SELECTION; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY;

ADULT; CLINICAL TRIALS; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; PATIENT SELECTION; PLACEBO EFFECT;

EID: 0031404976     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. American Psychiatric Association. DSM-III: The Diagnostic and Statistical Manual of Mental Disorders, 3d ed. Washington, DC: The Association, 1980.
2. American Psychiatric Association. DSM-III-R: The Diagnostic and Statistical Manual of Mental Disorders, 3d ed., revised. Washington, DC: The Association, 1987.
3. Amori, G, and Lenox, RH. Do volunteer subjects bias clinical trials? J. Clin. Psychopharmacol. 9(5):321-327, 1989.
4. Ansseau, M. "Differences in recruitment strategies for clinical trials." Paper presented at the 35th Annual Meeting of the American College of Neuropsychopharmacology (ACNP), San Juan, PR, December 1996.
5. Bielski, RJ, and Lydiard, RB. Therapeutic trial participants: Where do we find them and what does it cost? Psychopharmacol. Bull. 33(1):75-78, 1997.
6. Bisserbe, JC; Flament, M; and Weiller, E. "Tolerance of antidepressants: Is there a transatlantic difference?" Paper presented at the 35th Annual Meeting of the American College of Neuropsychopharmacology (ACNP), San Juan, PR, December 1996.
7. Brauzer, B, and Goldstein, BJ. Symptomatic volunteers: Another dimension for clinical trials. J. Clin. Pharmacol. 13:89-98, 1973.
8. Brown, WA. Predictors of placebo response in depression. Psychopharmacol. Bull. 24(1):14-17, 1988.
9. Covi, L; Lipman, RS; McNair, DM; and Czerlinsky, T. Symptomatic volunteers in multicenter drug trials. Prog. Neuropsychopharmacol. 3:521-533, 1979.
10. Fairchild, CJ; Rush, AJ; Vasavada, N; Giles, DE; and Khatami, M. Which depressions respond to placebo? Psychiatry Res. 18:217-226, 1986.
11. Hamilton, M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23:56-62, 1960.
12. Krupnick, J; Shea, T; and Elkin, I. Generalizability of treatment studies utilizing solicited patients. J. Consult. Clin. Psychol. 54(10):68-78, 1986.
13. Lecrubier, Y. "Similar designs but different results." Paper presented at the 35th Annual Meeting of the American College of Neuropsychopharmacology (ACNP), San Juan, PR, December 1996.
14. Miller, CA; Hooper, CL; and Bakish, D. A comparison of patients with major depressive disorder recruited through newspaper advertising versus consultation referrals for clinical drug trials. Psychopharmacol. Bull. 33(1):69-73, 1997.
15. Moller, H. "Differences observed between Europe and USA with comparators." Paper presented at the 35th Annual Meeting of the American College of Neuropsychopharmacology (ACNP), San Juan, PR, December 1996.
16. Montgomery, S. "Variability of the placebo response in Europe and the U.S." Paper presented at the 35th Annual Meeting of the American College of Neuropsychopharmacology (ACNP), San Juan, PR, December 1996.
17. Overall, JE; Goldstein, BJ; and Brauzer, B. Symptomatic volunteers in psychiatric research. J. Psychiatr. Res. 9:31-43, 1971.
18. Quitkin, FM; Rabkin, JG; Markowitz, JM; Stewart, JW; McGrath, PJ; and Harrison, W. Use of pattern analysis to identify true placebo response: A replication. Arch. Gen. Psychiatry 44:259-264, 1987.
19. Quitkin, FM; McGrath, PJ; Rabkin, JG; Stewart, JW; Harrison, W; Ross, DC; Tricamo, E; Fleiss, J; Markowitz, J; and Klein, DF. Different types of placebo response in patients receiving antidepressants. Am. J. Psychiatry 148:197-203, 1991a.
20. Quitkin, FM; Rabkin, JG; Stewart, JW; McGrath, PJ; Harrison, W; Ross, DC; Tricamo, E; Fleiss, J; Markowitz, J; and Klein, DF. Heterogeneity of clinical response during placebo treatment. Am. J. Psychiatry 148(2): 193-196, 1991b.
21. Rapaport, M; Frevert, T; Babior S; Zisook, S; and Judd, L. A comparison of demographic variables, symptom profiles, and measurements of functioning in symptomatic volunteers and an outpatient clinical population. Psychopharmacol. Bull. 31(1):111-114, 1995.
22. Rapaport, MH; Zisook, S; Frevert, T; Seymour, S; Kelsoe, JR; and Judd, LL. A comparison of descriptive variables for clinical patients and symptomatic volunteers with depressive disorders. J. Clin. Psychopharmacol 16(3):242-246, 1996.
23. Spilker, B, and Cramer, JA. Patient Recruitment in Clinical Trials. New York: Raven Press, 1992.
24. Stewart, JW; Quitkin, F; Liebowitz, M; McGrath, PJ; Harrison, WM; and Klein, DF. Efficacy of desipramine in depressed outpatients: Response according to Research Diagnostic Criteria diagnosis and severity of illness. Arch. Gen. Psychiatry 40:202-207, 1983.
25. Tedlow, JR; Fava, M; Uebelacker, LA; Alpert, JE; Nierenberg, AA; and Rosenbaum, JF. Are study dropouts different from completers? Biol. Psychiatry 40:668-670, 1996.
26. Thase, ME; Last, CG; Hersen, M; Bellack, AS; and Himmelhoch, JM. Symptomatic volunteers in depression research: A closer look. Psychiatr. Res. 11:25-33, 1984.